Skip to main content
PLOS One logoLink to PLOS One
. 2020 Oct 1;15(10):e0239951. doi: 10.1371/journal.pone.0239951

HIV prevalence, sexual risk behaviours and HIV testing among female sex workers in three cities in Sri Lanka: Findings from respondent-driven sampling surveys

Ariyaratne Manathunge 1, Jelena Barbaric 2, Tomislav Mestrovic 3, Sriyakanthi Beneragama 1, Ivana Bozicevic 2,*
Editor: Zixin Wang4
PMCID: PMC7529248  PMID: 33002081

Abstract

Sri Lanka has a low-level HIV epidemic. This study aims to provide evidence on HIV, syphilis and hepatitis B (HBV) prevalence, sexual risk behaviours and utilisation of HIV prevention interventions among female sex workers (FSW) in the cities Colombo, Galle, and Kandy. Using respondent-driven sampling (RDS), we recruited a total of 458 FSW in Colombo, 360 in Galle and 362 in Kandy from November 2017 to March 2018. Participants provided biological specimens for testing for infections and completed a behavioural questionnaire. We found no HIV nor HBV infections in Galle and Kandy, and low HIV (0.4%) and HBV surface antigen (0.6%) prevalence in Colombo. FSW in Colombo had higher positivity on Treponema pallidum-particle agglutination test (8.4%) compared to Galle (2.0%) and Kandy (2.5%). About two thirds of FSW heard of HIV in each of the cities. Around 90% of FSW used condom at last sex with a client in both Colombo and Galle, but considerably less in Kandy (57.1%). However, lower proportion of FSW used condoms every time during sex with clients in the past 30 day: 22.9% of FSW in Colombo, 26.6% in Kandy and 68.4% in Galle. Across cities, 17.5%-39.5% of FSW reported being tested for HIV in the past 12 months or knowing HIV positive status. The commonest reasons for never testing for HIV was not knowing where to test (54.2% in Colombo, 41.8% in Galle, 48.1% in Kandy) followed by inconvenient testing location (23.7% in Colombo and 31.1% in Kandy). HIV has not yet been firmly established among FSW in three cities in Sri Lanka, but the vulnerability towards HIV and STIs is substantial. HIV interventions should be intensified by expanding community-based HIV testing approaches, increasingawareness of HIV risks and addressing socio-structural vulnerabilities of FSW to HIV.

Introduction

Sri Lanka has a low-level HIV epidemic, with HIV prevalence estimates below 0.1%, which is lower than in most South Asian countries [1]. In 1930’s it was one the first in Asia Pacific to introduce the universal health coverage and its health system has a long track record of strong performance, despite 30 years of armed conflict which ended in 2009 [2]. This multi-ethnic, middle income country has a population of 21.7 million [3]. An estimated 3500 (3100–4000) people were living with HIV in Sri Lanka at the end of 2018 [1]. In 2018, 350 HIV infected persons were newly reported nationwide, the highest number in a year since 1987 when the first case was identified [4].

Using mapping and the multiplier methods in 2018, it was estimated that the population size of female sex workers (FSW) is 30,000 (plausibility range 20,000–35,000) [5]. Sex work in Sri Lanka is illegal and highly stigmatised [6]. The results of the first round of an integrated bio-behavioural survey (IBBS) among FSW in 2014/2015 included prevalence estimates for HIV, active syphilis and Treponema pallidum-particle agglutination assay (TPPA) positivity of 0.1%, 1.6% and 4.8% in Colombo, respectively [7]. In Galle, HIV prevalence was estimated at 1.0% whereas none of the participants tested positive for syphilis [7]. In Kandy, no HIV or syphilis infections were found [7]. Only about a third of the participants were able to correctly identify modes of transmission of HIV and reject major misconceptions about HIV transmission across the three cities. Whilst estimated 92% FSW used condoms at last sex with a client, only about a third tested for HIV 12 months before the survey and knew their HIV test result [7].

In Sri Lanka, HIV testing in key populations is carried out in sexually transmitted infection (STI) clinics, as well as through outreach testing services [4]. Whilst the number of STI clinic-based HIV testing among FSW rose moderately from 1135 tests performed in 2015 to 1715 in 2018, outreach testing among FSW rose markedly, from 490 tests in 2015 to 4064 tests in 2018 [4].

Being tested and knowing one’s HIV status is essential for initiation of ART and achieving the viral load suppression, which leads to improved outcomes for the individual and prevents HIV transmission at the population level [8]. FSW continue to bear a higher risk of HIV in many countries and are an important target population for a public health response to HIV [1, 8]. In order to monitor and further characterise HIV-related risk behaviours, uptake of HIV prevention services and HIV prevalence, we performed the second round of IBBS among key populations at risk of HIV. This paper aims to describe the key results of the second IBBS among FSW in Colombo, Galle and Kandy, assess correlates of not being tested for HIV and compare the key findings with those from the first IBBS carried out in 2015. Colombo, Galle and Kandy were selected for IBBS in 2018 because IBBS were done in these three cities in 2015. We hypothesised that there will be a significant increase in condom use with non-paying partners and ever testing for HIV when 2015 data are compared with 2018. They were selected for IBBS in 2015 because they are in the most populous provinces in Sri Lanka named Western Province (Colombo), Central Province (Kandy), and Southern Province (Galle) and because of the estimated population size of FSW. By repeating surveys in the same cities over time, temporal changes in HIV indicators can be assessed.

According to the findings of the latest Demographic and Health Survey in Sri Lanka done in 2016, which included ever married women aged 15–49, there are some substantial socio-economic differences among these three cities [9]. The percentage of women that cannot read and write was 3.4% in Colombo, 4.9% in Galle and 8.1% in Kandy and employed at the time of DHS were 39.0%, 38.2% and 31.5%, respectively. Experience of any form of domestic violence on a daily basis was reported by 16.3% of women in Kandy followed by 10.8% in Galle and 6.0% in Colombo.

Materials and methods

Study design, setting and participants

As FSW in Sri Lanka are a hard to reach population, we used respondent-driven sampling (RDS), a peer referral method which is widely used to sample such populations at risk for HIV [1013]. Furthermore, RDS was also used in the last IBBS survey of FSW in 2015, which allows for data comparison [7]. The results of the formative assessment, which included key informant interviews and focus group discussions in cities where RDS survey was planned, had revealed that the RDS would be feasible. We obtained ethical approval for the study from the Medical University of Sri Jayewardenepura in October 2017. Recruitment and data collection lasted from November 2017 to March 2018. Surveys took place at premises of non-governmental organisations (NGOs) that are providers of HIV prevention services to FSW.

Eligibility criteria included a female who has sold sex in exchange of money or goods in the six months before the survey, was older than 18 years of age, was able to provide verbal informed consent and resided or worked in the city where IBBS is done for at least 12 months before the survey. Personal network size question was worded as follows: “How many women do you know (they know your name and you know their name), who have sold sex in the last 6 months, and who are older than 18 years and reside in this city?” We identified initial respondents (seeds) during the formative assessment and started recruitment in Colombo with four, in Galle with two and in Kandy with seven seeds. Seeds were instructed to recruit with coupons given by study staff up to three other FSW from their social circle, who in turn were enrolled (if eligible) and instructed to refer other peers with coupons. Each coupon had its unique number that enabled to link participants with those who gave them coupons to participate in the study. Coupon numbers enable to monitor recruitment chains and issue secondary incentives, and are also necessary for RDS data analysis. Coupons also contained information about the address of the study site and time-period when the study site is open.

Participants provided informed consent before participating and were screened for eligibility.

After they gave an oral informed consent to participate, a survey staff member signed an informed consent form on their behalf. The Ethics Committee approved this consent procedure.

After completing a questionnaire, participants received HIV pre-test counselling and afterwards provided biological specimens for testing for infections. All participant information was kept anonymous and confidential.

Participants received a primary incentive of 2 USD for their participation in the study, and a secondary incentive of 1 USD for each person they recruited and who successfully completed the survey. There were no changes in the number of coupons per recruiter or any other relevant variation in study procedures during data collection.

Sample size calculation was set up to detect a 15% increase in consistent condom with a non-paying partner during 30 days before the survey from the baseline level of 32% in Colombo, 34% in Galle and 50% in Kandy in 2015, with 80% power and an alpha error of 5%. This gave a sample size of 442 respondents in Colombo, 307 in Galle and 341 in Kandy, which was rounded to 450 FSW in Colombo, and 350 FSW in Galle and Kandy, respectively.

Survey data collection and laboratory testing

We used behavioural questionnaire designed for the IBBS in 2014 and modified it according to the WHO-recommended questionnaires for bio-behavioural HIV surveys in key populations [14]. Indicators needed for the Global AIDS Monitoring (GAM) were collected based on the questionnaire [15]. The questionnaire included questions on demographics, sexual and drug-injecting behaviours, HIV testing, HIV-related knowledge, uptake of HIV prevention services and experience of violence. Indicators on sexual behaviours included age of the first vaginal and anal sex, length of time working as a sex worker, condom use at last sex with clients and regular partners, and consistent condom use with clients and regular partners during 30 days before the survey. Coverage with HIV interventions was defined according to the GAM guidelines, as receipt of at least two out of the following HIV prevention services from an NGO or a health care provider in the past three months: condoms and lubricants; counselling on condom use and safe sex; testing for sexually transmitted infections (STIs). The questionnaire was administered in a face-to-face interview using a tablet with Open Data Kit. The recruiter-recruit relationship was tracked using unique coupon numbers, which were entered into an MS Excel-based database.

We conducted testing for HIV, syphilis and hepatitis B virus (HBV) using rapid, point-of care tests on site from an intravenous blood draw. We performed serial HIV testing in line with the WHO and the national algorithm for HIV testing, using Alere Determine HIV (Alere Determine HIV-1/2 Ag/Ab Combo, Abbott Laboratories, USA) rapid test kit as the first, and in case of reactivity SD Bioline HIV 1/2 rapid test (SD Bioline HIV-1/2 3.0, Global Diagnostics, India) as the second, and ABON Tri-Line HIV Rapid Test (ABON Biopharm Hangzhou Co., China) as the third test. Determine Syphilis TP rapid test (Alere Determine™ Syphilis TP, Abbott Laboratories, USA) was used as the first test for syphilis, and those with reactive test results were re-tested using Venereal Disease Research Laboratory (VDRL) test (titre >8 was considered indicative of active syphilis). For hepatitis B testing, we used Determine HBsAg rapid test (Abbott Laboratories, USA) to determine the presence of the HBV surface antigen (HBsAg). Confirmatory testing was performed at the National Reference Laboratory of the National AIDS/STD Control Programme (NSACP). For quality assurance purposes, every 10th HIV and syphilis-negative sample was re-tested at the National Reference Laboratory of the NSACP. All respondents with confirmed positive test results were referred to the nearest STI clinic for further clinical assessment.

Statistical methods

We calculated the sample and estimated population proportions with 95% confidence intervals using RDS Analyst software version 0.61 [16]. We used the Gile’s sequential sampler (SS) estimator that is based on the inclusion probabilities that are calculated using participants self-reported network sizes, recruitment patterns and estimated population size [17]. According to the population size estimation data collected in 2013, Gile’s SS with population size estimate of 6,157 was used for Colombo, 1,754 for Galle and 2,204 for Kandy along with 0.95 confidence intervals and 5,000 bootstraps.

We analysed homophily, convergence/equilibrium and bottlenecks for key indicators (knowledge of HIV status, HIV prevention coverage, condom use at last commercial sex, discriminatory attitudes towards PLHIV, avoidance of stigma and discrimination, age and income [18].

We used a Chi-square significance test to compare selected categorical HIV indicators collected in the IBBS carried out in 2018 with those collected in the 2015 IBBS.

We used Stata 16.1 to perform unweighted bivariate and multivariate analysis [19]. Unweighted regression analysis was used due to concerns that weighted regression of RDS data does not perform well [20]. Multivariate logistic regression analysis was done to determine correlates associated with not being tested for HIV in the past 12 months or not knowing HIV positive status, which is the GAM indicator for HIV testing among key populations [15]. Independent variables used in the model included socio-demographic factors, sexual behaviours and knowledge about HIV. Knowledge about HIV was categorised as comprehensive knowledge, which meant correct answers on all five questions about HIV transmission outlined in the GAM 2020 Guidance, and non-comprehensive, which meant at least one incorrect answer to the five questions. We included factors associated with the outcome at p < 0.05 in the bivariable analysis, as well as age, in the final logistic regression model. We considered a result to be statistically significant in the multivariable analysis at p = 0.05. We excluded participants with missing values on any variable in the model. We included initial respondents (seeds) in the analysis.

Results

Recruitment patterns

We enrolled a total of 458 FSW in Colombo, 360 in Galle and 362 in Kandy. The predetermined sample size was reached at all three study-sites. The maximal chain length ranged from five in Kandy to nine in Colombo. Convergence was reached on all seven key indicators in Galle and in Kandy, and on five out of seven indicators in Colombo. The homophily on key variables ranged from 0.72 to 1.14 in Colombo, from 0.98 to 1.23 in Galle and from 0.99 to 1.12 in Kandy. The median network size was 10 (range: 1–300) in Colombo, 8 (range: 1–35) in Galle and 7 (range: 1–80) in Kandy.

Socio-demographic characteristics

The median age of FSW was 40 years in Colombo, 37 in Galle and 41 in Kandy. Median age of FSW recruited in IBBS in 2015 was 37 years in Colombo and Galle and 33 years in Kandy. Never attending school was reported by a minority in Colombo and Galle (6.6% and 5.0%, respectively), but by 19.1% FSW in Kandy. The majority of FSW had only some form of primary school education completed (47.9% in Colombo to 62.9% in Galle).

Earning less than 150 USD monthly was reported by 24.3% of FSW in Colombo, 30.1% in Galle and 45.9% in Kandy. This level of income was in the 2015 IBBS reported by 39.2% of respondents in Colombo, 35.4% in Galle and 17.3% in Kandy. Over 50% of FSW had sources of income other than sex work (Table 1).

Table 1. Sociodemographic characteristics of female sex workers in Colombo, Galle and Kandy, Sri Lanka, 2018.

Colombo Galle Kandy
n/N % (95% CI) n/N % (95% CI) n/N % (95% CI)
Age groups (in years)
 18–24 36/457 6.8 (4.3, 9.3) 20/360 5.3 (3.1, 7.6) 27/362 8.0 (4.8, 11.2)
 25–34 100/457 20.2 (15.7, 24.9) 121/360 30.3 (25.3, 35.3) 84/362 22.8 (18.4, 27.4)
 35–44 136/457 31.6 (26.0, 37.0) 117/360 31.4 (26.4, 36.4) 117/362 33.4 (28.6, 38.2)
 ≥ 45 185/457 41.4 (35.6, 47.3) 102/360 32.9 (27.3, 38.5) 134/362 35.8 (30.2, 41.4)
Earns money doing anything other than sex work (has other sources of income) 244/458 56.9 (50.8, 63.1) 222/357 64.7 (59.5, 69.8) 250/361 68.7 (63.7, 73.6)
Marital Status
 Single (Never married) 58/458 15.7 (11.3, 20.0) 31/359 7.7 (5.3, 10.1) 33/360 8.5 (5.3, 11.7)
 Married 202/458 39.0 (33.4, 44.7) 259/359 77.6 (73.4, 81.6) 176/360 46.9 (41.7, 52.2)
 Divorced/Separated 151/458 35.1 (29.1, 41.2) 43/359 8.9 (6.3, 11.5) 88/360 25.3 (20.7, 29.9)
 Widowed 47/458 10.2 (6.8, 13.6) 26/359 5.9 (3.8, 8.0) 63/360 19.2 (14.8, 23.7)
Ever been pregnant 295/457 57.7 (51.1, 64.2) 279/360 74.3 (68.7, 79.9) 323/356 90.9 (87.2, 94.6)
Number of children
 No children 235/421 61.7 (55.8, 67.7) 85/337 23.9 (19.1, 28.9) 111/356 30.9 (25.6, 36.5)
 One 90/421 18.1 (13.7, 22.5) 112/337 30.3 (24.8, 35.9) 120/356 35.1 (29.8, 40.4)
 Two 65/421 13.2 (9.8, 16.7) 84/337 25.5 (20.6, 30.3) 104/356 27.9 (23.3, 32.5)
 Three or more 31/421 6.9 (3.5, 10.4) 56/337 20.3 (15.0, 25.5) 21/356 6.0 (3.5, 8.6)
Visited an ANC clinic during most recent pregnancy 104/263 41.6 (32.3,50.9) 113/254 40.4 (33.2, 47.2) 138/322 40.1 (34.6–45.6)
Offered an HIV test at the ANC or maternity during most recent pregnancy 60/104 63.3 (46.6, 80.3) 54/113 46.5 (33.4, 57.9) 21/137 13.5 (7.0–19.7)

Weighted population estimates and 95% confidence intervals (CI).

ANC = Ante-natal care.

Knowledge, risk-related behaviors and experience

Around two thirds of FSW have heard of HIV in each of three cities, but FSW knowledge about HIV prevention varied, as only 15.0% of FSW correctly answered all five questions about HIV transmission in Colombo, 27.8% in Kandy and 41.5% in Galle (Table 2). Compared to 2015, there has been a decline in comprehensive knowledge in Colombo and Kandy in 2018, and an increase in Galle. Less than 20% of FSW across the cities perceived their personal HIV risk as high.

Table 2. Knowledge about HIV, sexual behaviors and health care utilization among female sex workers in Colombo, Galle and Kandy, Sri Lanka, in 2015 and 2018.

Colombo Galle Kandy
2015 2018 2015 2018 2015 2018
n/N % (95% CI) n/N % (95% CI) n/N % (95% CI) n/N % (95% CI) n/N % (95% CI) n/N % (95% CI)
HIV-related knowledge
Ever heard of HIV/AIDS 474/605 77.0 (72.6, 81.1) 314/454 67.2 (61.7, 72.7)* 235/302 78.9 (74.4, 83.7) 227/354 67.3 (61.9, 72.7) * 300/354 85.4 (81.3, 89.7) 257/362 67.6 (62.3, 72.9) *
Comprehensive knowledge about HIV prevention 195/604 31.3 (27.3, 35.3) 80/454 15.0 (10.8, 19.2) * 84/301 28.0 (22.7, 33.3) 129/354 41.5 (35.9, 47.1) * 183/353 50.1 (45.1, 54.8) 104/353 27.8 (22.5, 33.1) *
Knows HIV can be transmitted from mother to her unborn child 376/605 59.0 (54.5, 62.3) 272/357 57.5 (51.5, 63.4)* 209/302 68.2 (62.5, 73.8) 257/360 74.5 (69.6, 79.3) 302/354 89.1 (86.6, 92.3) 259/362 68.9 (63.9, 73.8) *
Ever heard of ART 176/605 29.6 (25.8, 33.4) 236/458 51.8 (45.4, 58.2)* 99/300 33.0 (26.6, 39.4) 70/360 22.8 (17.3, 28.4)* 216/354 64.2 (59.0, 69.9) 98/362 24.7 (20.1, 29.3)*
Knows where to receive an HIV test 392/605 64.1 (60.0, 68.0) 324/458 65.9 (60.0, 71.8) * 199/302 67.0 (60.3, 74.0) 242/359 68.4 (62.6, 74.2) 229/354 63.7 (57.6, 69.5) 236/357 61.2 (55.6, 67.0)
HIV-related behaviours
Perceives personal HIV risk as high 209/604 33.2 (29.1, 37.3) 111/457 19.8 (15.5, 24.1) * 62/301 19.3 (14.2, 24.0) 69/360 14.2 (11.1, 17.2) 65/354 15.5 (10.9, 19.6) 73/361 17.7 (13.8, 21.7)
Not discussed HIV with any sexual partner 262/474 57.7 (52.9, 62.7) 137/314 41.6 (34.3, 48.9) 62/234 25.5 (19.6, 31.3) 164/227 65.4 (54.6, 75.7) * 32/300 9.0 (5.3, 12.3) 129/257 52.1 (45.5, 58.8) *
Considers male condoms affordable 511/598 85.7 (82.5–89.0) 274/449 65.9 (60.4, 71.4)* 195/290 65.0 (58.1, 71.4) 190/335 61.9 (56.2. 67.6)* 325/347 94.5 (92.2, 97.0) 58/308 19.8 (14.6, 25.0)*
Used condom at last sex with a client 567/604 94.0 (92.0, 96.0) 424/457 92.2 (88.9, 95.5) 269/302 87.7 (83.6, 91.6) 307/360 86.6 (83.4, 89.9) 338/354 94.3 (91.2, 97.2) 207/343 57.1 (50.8, 63.2)*
Used condom at last sex with a regular partner 337/375 90.4 (87.5, 93.4) 220/286 78.6 (72.6, 84.7)* 133/151 86.4 (80.9, 91.5) 62/155 36.5 (29.0, 44.1)* 71/152 32.3 (22.8, 38.8) 27/144 16.9 (9.8, 23.8)*
Ever tested for HIV 332/605 53.0 (48.6, 57.2) 252/452 50.8 (44.8–56.8) 127/302 40.1 (34.0, 45.8) 175/352 49.7 (43.9, 55.6) 127/354 35.6 (29.7, 41.4) 155/361 39.8 (34.4, 45.4)
Health care utilization
Tested for HIV in the past 12 months or knowing HIV positive status 261/605 41.6 (37.2, 45.9) 158/452 31.5 (25.7, 37.3)* 72/302 22.1 (17.1, 26.7) 127/352 39.5 (33.1, 46.0)* 95/354 26.5 (21.2, 31.7) 70/361 17.5 (13.5, 21.5)*
Refused health care on the basis of being a FSW 16/604 2.7 (1.2, 4.2) 75/451 16.6 (12.9, 20.4)* 14/300 4.6 (2.3, 6.9) 12/358 2.8 (1.2, 4.4) 11/354 2.3 (0.8, 3.6) 5/360 1.2 (0.2, 2.1)

Weighted population estimates and 95% confidence intervals (CI)

All answers correct on five questions related to identifying ways of preventing the sexual transmission of HIV and rejecting major misconceptions about HIV transmission.

ART = anti-retroviral treatment, ANC = antenatal clinic.

* Significant difference (p<0.05) in indicator values between the survey carried out in 2018 and the 2015 survey.

Median reported age at first vaginal sex was 18 years (range 12–35) in Colombo, 18 years (range 12–40) in Galle and 21 years (range 12–38) in Kandy. Median reported age at first anal sex was 21 years (range 14–48) in Colombo, 19 years (range 14–45) in Galle and 24 years (range 15–48) in Kandy. Median reported length of time working as a FSW was 19 years (range 0–49) in Colombo, 9 years (range 0–46) in Galle and 8 years (range 1–48) in Kandy.

Median total number of paying partners in the past seven days was 6 (range 1–28) in Colombo, 4 (range 0–20) in Galle and 3 (range 1–15) in Kandy.

Around 90% of FSW used condom at last sex with a client in both Colombo and Galle, but considerably less in Kandy (57.1%). However, condoms were reportedly used every time during sex with clients in the past 30 day less frequently–by 22.9% of FSW in Colombo, 26.6% in Kandy and 68.4% in Galle.

Around 80% of FSW used condom at last sex with a regular partner in Colombo, 36.5% in Galle, and 16.9% in Kandy, which is substantially less than in 2015. With regular partners every time condom use in the past 30 days was reported by 22.3% in Colombo, 11.5% in Galle and 4.4% in Kandy.

None of the participants in Galle reported ever injecting drugs for non-medical purposes, while this was the case with 4.8% of FSW in Colombo and 0.9% in Kandy.

Ever been sexually assaulted or raped was reported by 10.9% of FSW in Colombo, 1.2% in Galle and 15.5% in Kandy.

Coverage with HIV prevention services and HIV testing

In 2018, approximately a half of FSW in Colombo and Galle and 39.8% in Kandy reported ever being tested for HIV, which is a slight increase compared to 2015 in Galle and Kandy, and a decline in Colombo (Table 2). In 2018, the commonest reasons in all three cities for never testing for HIV was not knowing where to test (54.2% in Colombo, 41.8% in Galle, 48.1% in Kandy) followed by inconvenient testing location (23.7% in Colombo and 31.1% in Kandy).

The vast majority of FSW in Colombo (80.1%) and Galle (92.6%) were very satisfied or satisfied with the quality of services provided during last HIV testing was received, and 64.2% of FSW in Kandy.

Around 40% of respondents visited an ANC during most recent pregnancy but there was a wide variability in reporting being offered an HIV test at an ANC setting–from 13.5% in Kandy to 63.3% in Colombo.

Estimates of coverage with HIV prevention interventions in the past three months were low: 12.5% (95% CI 8.7–16.3) among FSW in Colombo, 15.4% (95% CI 9.8–20.7) in Galle and 9.6% (95% CI 6.5, 12.6) in Kandy. Affordability of male condoms declined when 2018 data are compared to 2015 and was in 2018 reportedly the highest in Colombo (65.9% of FSW reported condoms to be affordable) and the lowest in Kandy (19.8%). The two commonest sources of condoms in Colombo and Galle were private pharmacy and chemist, while in Kandy neighbourhood markets/stands. In Colombo an estimated 21.4% of FSW usually obtain condoms from NGOs and outreach services, and in Galle and Kandy only around 16%.

Prevalence of HIV, syphilis and HBV

No HIV infections were found in Kandy and Galle while HIV prevalence was 0.4% (95% CI 0.0–1.0) among FSW in Colombo. In Colombo, 8.4% (95% CI 6.3–10.6) of FSW were ever infected with syphilis, as confirmed by a positive TPPA test, while positive VDRL was found among 0.4% (95% CI 0.0–0.9). In Galle, 2.0% (95% CI 0.0, 4.6) of FSW were ever infected with syphilis, and VDRL-reactive were 0.7% (95% CI 0.0–1.6). This was similar to findings in Kandy, with 2.5% (95% CI 0.7–4.2) ever infected with syphilis and 0.6% (95% CI 0.0–1.5) VDRL-reactive. The prevalence of HBsAg positivity was 0.6% (95% CI 0.0–1.3) in Colombo, while no cases were found in the other two cities.

Correlates of not being tested for HIV in the past 12 months or not knowing HIV positive status

The results of the multivariable analysis show that FSW who did not answer correctly all five questions about HIV transmission had higher odds of not being tested for HIV in the past 12 months or not knowing HIV positive status compared to those who did, with adjusted OR (aOR) of 3.2 (95% CI 1.9, 5.3) in Colombo, 5.1 (95% CI 2.1, 12.4) in Galle and 3.0 (95% CI 1.1, 9.0) in Kandy (Table 3). Divorced, widowed or separated FSW and those who were single had higher odds of not testing compared to married FSW in Colombo. In Galle, FSW with 11–25 paying partners in the last 30 days had marginally higher odds of not being tested compared to FSW with 0–10 partners. In Kandy, FSW who did not use condom at last sex with a non-paying partner had 8.5 (95% CI 3.1, 23.1) higher odds of not being tested, compared to FSW who did. Not using condoms at last sex with a non-paying partner was marginally associated with not being tested for HIV in the past 12 months or not knowing HIV positive status in Colombo and Galle.

Table 3. Factors associated with not being tested for HIV in the past 12 months or not knowing HIV positive status among FSW in Colombo, Galle and Kandy, Sri Lanka: Bivariable and multivariable logistic regression with unadjusted odds ratios (OR) and adjusted ORs (aOR) with confidence intervals (CI), 2018.

Colombo Galle Kandy
Not tested in the past 12 months or not knowing HIV positive status/ No total OR (CI 95%) aORa (CI 95%) Not tested in the past 12 months or not knowing HIV positive status /No total OR (CI 95%) aOR (CI 95%) Not tested in the past 12 months or not knowing HIV positive status /No total OR (CI 95%) aOR (CI 95%)
Age p = 0.088 p = 0.002 1.0 (0.9–1.1) p = 0.683 0.9 (0.9–1.0)
18–24 23/35 1 1 18/19 1 20/27 1.0
25–40 140/199 1.2 (0.6, 2.7) 1.4 (0.6, 3.7) 125/192 0.1 (0.01, 0.8) 118/146 1.4 (0.6, 3.8)
>41 131/218 0.8 (0.4,1.7) 0.9 (0.3–2.2) 82/141 0.08 (0.01, 0.6) 153/188 1.5 (0.6, 3.9)
Monthly income p = 0.770 p = 0.143 p = 0.015
<100 USD 217/336 1 - 153/228 1 _ 158/207 1.0 1.0
>101 USD 76/115 1.1 (0.7,1.7) 71/120 0.7 (0.4, 1.1) 133/154 1.9 (1.1, 3.4) 1.1 (0.4–3.4)
Marital status p = 0.004 p = 0.519 p = 0.031
Married 114/201 1 1 157/252 1 - 134/175 1.0 1.0
Single, never married 40/56 1.9 (1.0, 3.6) 2.2 (1.0, 4.7)* 21/30 1.4 (0.6, 3.2) 24/33 0.8 (0.4, 1.9) 1.5 (0.3, 7.9)
Divorced, widowed, separated 140/195 1.9 (1.3, 3.0) 2.2 (1.2, 3.8) 47/69 1.3 (0.7, 2.3) 131/151 2.0 (1.1, 3.6) 2.0 (0.5, 8.0)
Number of partners in the past 30 days p = 0.002 p = 0.054 p = 0.242 -
0–10 34/69 1 1 67/120 1 1 112/132 1.0
11–25 154/239 1.9 (1.1, 3.2) 1.1 (0.5, 2.4) 101/144 1.9 (1.1, 3.1) 3.3 (1.1, 10.3)* 172/219 0.6 (0.4, 1.2)
>26 106/144 2.9 (1.6, 5.2) 1.0 (0.4, 2.5) 57/88 1.5 (0.8, 2.6) 1.1 (0.4, 3.3) 7/10 0.4 (0.1, 1.7)
Condom use at last sex with a non-paying partner p = 0.0175 p = 0.025 p<0.001 1.0
Yes 150/244 1 1 34/60 1 1 18/33 1.0 8.5 (3.1, 23.1)*
No 50/65 2.1 (1.1, 3.9) 1.9 (1.0, 3.8)* 71/96 2.1 (1.1, 4.3) 2.1 (1.0, 4.6)* 114/124 9.5 (3.7, 24.4)
Places where clients are sought p = 0.0181 p<0.001 p = 0.144
Fixed locations 175/257 1 - 112/163 1 1 62/76 1.0 -
Outdoor places 81/144 0.6 (0.4, 0.9) 62/83 1.3 (0.7, 2.5) 1.0 (0.4, 2.5) 100/137 0.6 (0.3, 1.2)
Internet, phone§ 36/48 1.4 (0.7, 2.8) 51/106 0.4 (0.3, 0.7) 0.9 (0.3, 2.5) 128/145 1.7 (0.8, 2.7)
Knowledge about HIV (GAM) p<0.0181 p<0.001 p<0.001
Score 5 33/79 1 1 54/123 1 1.0 53/ 104 1.0 1.0
Scores 0–4 257/369 3.2 (1.9, 5.3) 3.9 (1.9, 8.0)* 165/223 3.6 (2.3, 5.8) 5.1 (2.1, 12.4)* 229/ 248 11.6 (6.3, 21.3) 3.0 (1.1, 9.0)*

Age was included in the multivariate model as a continuous variable due to p-values getting close to the value of 1 if age was treated as a categorical variable.

- not significant in the bivariable analysis and therefore not included in the multivariable logistic regression model.

Fixed locations: brothel, bar, hotel, motel, spa, massage parlour; Outdoor places: street, park, truck stops;

§Also includes finding partners through an intermediary (pimp) and through friends;

Score 5 implies that answers about all five questions about HIV transmission were correct;

* significantly associated with the outcome in the adjusted multivariate regression model

Discussion

We found no HIV infections in Galle and Kandy, and low HIV prevalence in Colombo (0.4%). FSW in Colombo had higher TPPA positivity (8.4%) compared to other two cities. Such findings are encouraging and suggest much lower HIV prevalence among FSW in Sri Lanka compared to the other countries in South East Asia, such as Indonesia (10% in direct and 3% in indirect FSW), India (2.2% at the national level, ranging from 0.7–7.4% across regions) and Myanmar (11–25% across cities) [2123]. This low HIV prevalence among FSW in three cities in Sri Lanka might be explained by potentially still low HIV transmission among the heterosexual population. The HIV case reporting system in Sri Lanka indicates a total of 350 HIV cases that were newly reported during 2018, which is an increase of 23% from the number reported during 2017 [4]. This increase in reported cases is driven by men: in the period 2011–2018 the number of reported cases increased from 78 to 285 in men, respectively, while around 60 cases were annually reported in women.

Our results suggest that the proportion of FSW reporting ever been tested for HIV somewhat increased from 2015 to 2018 in Galle and Kandy, and declined slightly in Colombo. HIV testing in the past 12 months or knowing HIV positive status remains low with only 17.5%-39.5% of FSW across cities reporting testing for HIV in the last 12 months or knowing HIV positive status. Although HIV prevention services for key populations were scaled up in the period 2015–2018, IBBS findings imply that certain sexual risk practices were more prevalent in 2018 compared to 2015. Use of condoms at last sex with clients in Kandy and at last sex with regular partners in all three cities declined when 2015 is compared to 2018. As reported by survey respondents, affordability of condoms significantly decreased from 2015–2018 in all three cities, which could be an explanation for lower condom use. In addition, comprehensive knowledge about HIV prevention significantly declined when the 2015 IBBS findings are compared to 2018. This points to a need for more effective delivery of HIV prevention and testing services to FSW and putting emphasis on achieving much better coverage with HIV prevention. However, some of the differences in reported sexual behaviours, HIV knowledge and HIV testing between the 2015 and 2018 IBBS could be explained by differences in socio-demographic characteristics of FSW recruited in these two rounds of surveys. This might be in particular relevant for Kandy as in the 2018 survey respondents were somewhat older and of lower income.

Multivariate analysis highlighted the importance that adequate knowledge of HIV has on higher uptake of HIV testing, which is consistent with the findings of prior international research [2426]. The results demonstrate that FSW who did not use condoms at last sex with a non-paying partner had lower odds of testing for HIV. These findings complement those from other studies, which found a negative association between inconsistent condom use with non-paying partners and HIV testing, possibly due to lower risk perception of women who are in longer-term relationships [2730]. Condom use with regular partners was substantially lower compared to paying partners, as has repeatedly been shown elsewhere, despite the fact that most FSW did not know the HIV status of their partners [31, 32]. Respondents in our study were reporting considerably more frequently condom use at last sex with paying and non-paying partners compared to consistent condom use during a 30 days time-frame. As suggested by Baral et al., always using condoms may be a more representative measure of actual condom use compared to condom use at last sex [33].

In Colombo, FSW who were married were more likely to get tested, which might be explained by their higher motivation to stay healthy and support their families [34, 35].

The systematic review of barriers and facilitators to HIV testing amongst FSWs found that the two barriers most commonly reported were costs (including transportation, formal/informal payments) and stigma [36]. In our study, the most important reason given for not testing for HIV was not knowing where to test. Therefore, raising awareness of HIV testing via targeted campaigns along with educational activities should be the cornerstone of HIV prevention efforts among FSW in Sri Lanka. Innovative testing approaches are needed to reach FSW with HIV testing such as mobile testing services, social-network testing, self–testing and, importantly, testing of partners [8]. Interventions for FSWs should promote consistent condom use, increase skills in negotiating condom use across all types of partnerships and self-efficacy of sex workers when interacting with clients and regular partners. It is also important to reach with HIV prevention more hidden FSW that are not finding partners at fixed locations and at public places. The percentage of FSW who reported finding partners through mobile phone, Internet or an intermediary ranged from 10.9% in Colombo to 38.7% in Kandy.

We also found geographical disparities in utilization of HIV prevention among FSW, with the poorest utilization in Kandy. Sub-optimal coverage with HIV interventions is likely due to both insufficient levels of service provision but also limited uptake of services because of clandestine nature of sex work and stigma. Other reasons could be underlying socio-economic differences among these geographical areas in Sri Lanka. As found in the latest DHS, proportion of women of reproductive age who are illiterate is higher in Kandy compared to Colombo and Galle, and a lower proportion are employed. Findings from our study also indicate lower earnings of FSW in Kandy compared to two other cities, which might have an impact on utilization of HIV prevention services.

The majority of women in this study had an occupation outside of sex work, which might suggest that they engage in occasional transactional sex based on financial need. Addressing financial and social vulnerabilities of these women is therefore of utmost importance. The results highlight the need to address the quantity of service provision and focus on empowerment–based approaches that address the socio-structural vulnerabilities of FSWs to HIV [37].

Study limitations

There are a number of limitations to our study. FSW provided self-reported data, which could be subject to recall bias. Social desirability bias could impact on results, particularly on reporting of sexual behaviours. This source of bias might have been limited due to the engagement of trained study personnel who were experienced in working with FSWs. Comparisons of surveys carried out in 2015 and 2018 is impacted by the extent of those biases, as well as selection bias and different socio-demographic characteristics of respondents.

The use of RDS increases the generalisability of the results by adjusting for network size, homophily, and by limiting recruitment per respondent.

Conclusions

Findings from this study reveal the similarities and heterogeneities in vulnerabilities towards HIV among FSWs in the three cities in Sri Lanka. HIV has not yet been firmly established among FSW in these cities, which provides a window of opportunity to avoid progression of HIV transmission. This can be achieved by larger-scale implementation of behavioural, biomedical and structural interventions that are known to be effective.

Supporting information

S1 File

(SAV)

S2 File

(SAV)

S3 File

(SAV)

Acknowledgments

We would like to thank the study participants and the staff of the National STD/AIDS Control Programme in Sri Lanka, Management Frontiers Ltd., and the staff from the following NGOs that participated in data collection: Abhimani, Saviya Development, Laksetha Sahana Sewa, Family Planning Association, Wayamba Govi Sanwardhana Padanama, Rajarata Gami Pahana, Saviya Development Foundation, Natural Resource Development Foundation and Sri Lanka Human Development Foundation.

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

The study was funded by the New Funding Model Grant, 2016-2018 of the Global Fund to Fight AIDS, Tuberculosis and Malaria (https://www.theglobalfund.org/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.UNAIDS Data 2019. Geneva: UNAIDS, 2020.
  • 2.Smith O. Sri Lanka: Achieving Pro-Poor Universal Health Coverage without Health Financing Reforms Universal Health Coverage Study Series No. 38, World Bank Group, Washington, DC: 2018. [Google Scholar]
  • 3.The World Bank. Sri Lanka | Data 2020. https://data.worldbank.org/country/sri-lanka (accessed 15 January 2020).
  • 4.Annual Report 2018. Colombo: National STD/AIDS Programme, Ministry of Health, Sri Lanka; 2018.
  • 5.Bozicevic I, Manathunge A, Dominkovic Z, Beneragama S, Kriitmaa K. Estimating the population size of female sex workers and transgender women in Sri Lanka. PLoS One 2020;15:e0227689 10.1371/journal.pone.0227689 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Laws Concerning Commercial Sex and HIV AIDS Prevention. Colombo: National STD/AIDS Programme, Ministry of Health, Sri Lanka; 2013. [Google Scholar]
  • 7.Integrated biological and behavioural surveillance (IBBS) survey among key populations at higher risk at HIV in Sri Lanka. Colombo: National STD/AIDS Programme, Ministry of Health, Sri Lanka, 2015. [Google Scholar]
  • 8.Consolidated guidelines on HIV testing services for a changing epidemic. Geneva: World Health Organization, 2019. [Google Scholar]
  • 9.Department of Census and Statistics (DCS) and Ministry of Health, Nutrition and Indigenous Medicine 2017. Sri Lanka Demographic and Health Survey 2016 Sri Lanka.
  • 10.Heckathorn DD. Respondent-Driven Sampling: A New Approach to the Study of Hidden Populations. Soc Probl. 1997;44:174–99. 10.2307/3096941 [DOI] [Google Scholar]
  • 11.Malekinejad M, Johnston LG, Kendall C, Kerr LRFS, Rifkin MR, Rutherford GW. Using Respondent-Driven Sampling Methodology for HIV Biological and Behavioral Surveillance in International Settings: A Systematic Review. AIDS Behav. 2008;12:105–30. 10.1007/s10461-008-9421-1 [DOI] [PubMed] [Google Scholar]
  • 12.White RG, Hakim AJ, Salganik MJ, Spiller MW, Johnston LG, Kerr L, et al. Strengthening the Reporting of Observational Studies in Epidemiology for respondent-driven sampling studies: “STROBE-RDS” statement. J Clin Epidemiol. 2015;68:1463–71. 10.1016/j.jclinepi.2015.04.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Lafort Y, Greener R, Roy A, Greener L, Ombidi W, Lessitala F et al. HIV Prevention and Care-Seeking Behaviour Among Female Sex Workers in Four Cities in India, Kenya, Mozambique and South Africa. Trop Med Int Health. 2016; 21:1293–1303. 10.1111/tmi.12761 [DOI] [PubMed] [Google Scholar]
  • 14.WHO, CDC, UNAIDS, FHI 360. Biobehavioral Survey Guidelines for Populations at Risk for HIV. Geneva: World Health Organization; 2017 [Google Scholar]
  • 15.Global AIDS Monitoring 2020. Geneva: UNAIDS, 2019. https://www.unaids.org/en/resources/documents/2019/Global-AIDS-Monitoring (accessed 15 April 2020). [Google Scholar]
  • 16.Handcock MS, Fellows IE, Gile KJ. RDS analyst: Software for the analysis of respondent-driven sampling data, version 0.61. http://wiki.stat.ucla.edu/hpmrg/index.php/RDS_Analyst_Install (accessed 9 April 2020).
  • 17.Gile KJ. Improved Inference for Respondent-Driven Sampling Data With Application to HIV Prevalence Estimation. J Am Stat Assoc. 2011;106:135–46. 10.1198/jasa.2011.ap09475 [DOI] [Google Scholar]
  • 18.Gile KJ, Johnston LG, Salganik MJ. Diagnostics for Respondent-driven Sampling. J R Stat Soc Ser A Stat Soc. 2015;178:241–69. 10.1111/rssa.12059 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.StataCorp. 2019. Stata Statistical Software: Release 16. College Station, TX: StataCorp LLC. [Google Scholar]
  • 20.Avery L, Rotondi N, McKnight C, Firestone M, Smylie J, Rotondi M. Unweighted regression models perform better than weighted regression techniques for respondent-driven sampling data: results from a simulation study. BMC Med Res Methodol. 2019;19:202 10.1186/s12874-019-0842-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Report on Integrated Bio-Behavioural HIV Surveys. Jakarta, Ministry of Health Republic of Indonesia, 2011.
  • 22.Myanmar Integrated Biological and Behavioural Surveillance Surveys and Population Size Estimation among Female Sex Workers. Naypyitaw: Ministry of Health and Sports, 2015. [Google Scholar]
  • 23.National AIDS Control Organization (2015). National Integrated Biological and Behavioural Surveillance (IBBS), India 2014–15. New Delhi: NACO, Ministry of Health and Family Welfare, Government of India. [Google Scholar]
  • 24.Sayarifard A Kolahi A Hamedani M. Frequency of performing HIV test and reasons of not-testing among female sex workers. Am J Epidemiol. 2011;173:S197 [Google Scholar]
  • 25.Beattie TSH, Bhattacharjee P, Suresh M, Isac S, Ramesh BM, Moses S. Personal, interpersonal and structural challenges to accessing HIV testing, treatment and care services among female sex workers, men who have sex with men and transgenders in Karnataka state, South India. J Epidemiol Community Health. 2012;66 Suppl 2:ii42–48. 10.1136/jech-2011-200475 [DOI] [PubMed] [Google Scholar]
  • 26.Chanda MM, Perez-Brumer AG, Ortblad KF, Mwale M, Chongo S, Kamungoma N, et al. Barriers and Facilitators to HIV Testing Among Zambian Female Sex Workers in Three Transit Hubs. AIDS Patient Care STDs. 2017;31:290–6. 10.1089/apc.2017.0016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Tran BX, Nguyen LT, Nguyen NP, Phan HTT. HIV voluntary testing and perceived risk among female sex workers in the Mekong Delta region of Vietnam. Glob Health Action. 2013;6:20690 10.3402/gha.v6i0.20690 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Wang Y, Li B, Pan J, Sengupta S, Emrick CB, Cohen MS, et al. Factors associated with utilization of a free HIV VCT clinic by female sex workers in Jinan City, Northern China. AIDS Behav. 2011;15:702–10. 10.1007/s10461-010-9703-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Kerrigan D, Ellen JM, Moreno L, Rosario S, Katz J, Celentano DD, et al. Environmental-structural factors significantly associated with consistent condom use among female sex workers in the Dominican Republic. AIDS. 2003;17:415–23. 10.1097/00002030-200302140-00016 [DOI] [PubMed] [Google Scholar]
  • 30.Deering KN, Bhattacharjee P, Bradley J, Moses SS, Shannon K, Shaw SY, et al. Condom use within non-commercial partnerships of female sex workers in southern India. BMC Public Health 2011;11 Suppl 6:S11 10.1186/1471-2458-11-S6-S11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Luchters S, Richter ML, Bosire W, Nelson G, Kingola N, Zhang X-D, et al. The contribution of emotional partners to sexual risk taking and violence among female sex workers in Mombasa, Kenya: a cohort study. PLoS One. 2013;8:e68855 10.1371/journal.pone.0068855 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Lafort Y, Greener R, Roy A, Greener L, Ombidi W, Lessitala F, et al. HIV prevention and care-seeking behaviour among female sex workers in four cities in India, Kenya, Mozambique and South Africa. Trop Med Int Health 2016;21:1293–303. 10.1111/tmi.12761 [DOI] [PubMed] [Google Scholar]
  • 33.Baral S, Ketende S, Green JL, Chen P-A, Grosso A, Sithole B, et al. Reconceptualizing the HIV epidemiology and prevention needs of Female Sex Workers (FSW) in Swaziland. PLoS One 2014;9:e115465 10.1371/journal.pone.0115465 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Grayman JH, Nhan DT, Huong PT, Jenkins RA, Carey JW, West GR, et al. Factors associated with HIV testing, condom use, and sexually transmitted infections among female sex workers in Nha Trang, Vietnam. AIDS Behav. 2005;9:41–51. 10.1007/s10461-005-1680-5 [DOI] [PubMed] [Google Scholar]
  • 35.Chiao C, Morisky DE, Ksobiech K, Malow RM. Promoting HIV testing and condom use among Filipina commercial sex workers: findings from a quasi-experimental intervention study. AIDS Behav. 2009;13:892–901. 10.1007/s10461-008-9418-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Tokar A, Broerse JEW, Blanchard J, Roura M. HIV Testing and Counseling Among Female Sex Workers: A Systematic Literature Review. AIDS Behav. 2018;22:2435–57. 10.1007/s10461-018-2043-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Kerrigan D, Kennedy CE, Morgan-Thomas R, Reza-Paul S, Mwangi P, Win KT, et al. A community empowerment approach to the HIV response among sex workers: effectiveness, challenges, and considerations for implementation and scale-up. Lancet 2015;385:172–85. 10.1016/S0140-6736(14)60973-9 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Zixin Wang

14 Jul 2020

PONE-D-20-14017

HIV prevalence, sexual risk behaviours and HIV testing among female sex workers in three cities in Sri Lanka: Findings from respondent-driven sampling surveys

PLOS ONE

Dear Dr. Bozicevic,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Aug 28 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Zixin Wang, PhD.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please amend your current ethics statement to address the following concerns: Please explain why written consent was not obtained, how you recorded/documented participant consent, and if the ethics committees/IRBs approved this consent procedure.

3. Please provide more information on the coupons given out as part of recruitment.

4. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors conducted a second round of IBBS survey among female sex workers in Colombo, Galle, and Kandy, and provided valuable results about HIV prevalence, risk behaviors, and related perceptions. This study adds to our knowledge about the HIV/AIDS epidemic in Sri Lanka, therefore of significance. I would agree for the manuscript to be published if the authors can provide more detail for the following suggestions.

Major:

Could the author explain the reason for choosing the three cities as the research site? How representative are the results of these three cities?

Minor:

1.There is a lack of background data on sexual risk behaviors and HIV testing among female sex workers in Sri Lanka in the introduction part. Please provide more data if possible.

2.Please clarify the reason for choosing “consistent condom use with a non-paying partner for 30 days” as the indicator in sample size estimation.

3.Please add more details of the measurement of Sexual risk behaviors since it is one of the major outcomes.

4.Please clarify why only the result of Colombo was weighted in table 1.

5.Please provide the statistical testing results (like P-value) in the comparison between two rounds of the survey in different cities in table 2. (2015 versus 2018)

6.Please mark the significance of aOR in table 3.

Overall, the manuscript is well written and showed us a more up-to-date picture of HIV infection and perception among female sex workers in Sri Lanka. Apart from the above problems, language and format should be improved before getting published.

Reviewer #2: Their investigations conducted a study in Sri Lanka, and described the HIV, syphilis and hepatitis B (HBV) prevalence, sexual risk behaviors and utilization of HIV prevention interventions among female sex workers (FSW), this study could provide more information of interventions for FSW in Sri Lanka. I have several comments for the authors to consider.

1. In the introduction, the authors should introduce why they chose the three places (Colombo, Galle and Kandy) as the study sites?

2. The authors should provide a further implication of this study, not only to monitor and further characteristics HIV-related risk behaviors, uptake of HIV prevention services and HIV prevalence?

Results

1. Is the FSW collected in 2015 and 2018 the same group? Is there any difference between the FSW in 2015 and 2018? Could the authors add the data of 2015 and compared with that of 2018 in Table 1 for the demographic characteristics?

2. The unit of age in Table 1 should be added.

3. Can you rearrange the contents of Table 2 logically, which is very difficult to read. Also, can you compare the knowledge about HIV, sexual behaviors and health care utilization between 2015 and 2018?

4. If the author compares the differences between the three regions, more information may be provided.

Discussion

1. The author should add more information about the three study sites of social economics, which could give more information to explain the differences of factors associated not being tested for HIV in the past 12 months or not knowing HIV positive status among FSW.

2. Selection bias may be a limitation in this study.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2020 Oct 1;15(10):e0239951. doi: 10.1371/journal.pone.0239951.r002

Author response to Decision Letter 0


20 Jul 2020

Comments of the Editorial Office and Responses of the authors

Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming

Thank you, this has been corrected.

Please amend your current ethics statement to address the following concerns: Please explain why written consent was not obtained, how you recorded/documented participant consent, and if the ethics committees/IRBs approved this consent procedure.

Written consent was not obtained as it is a standard practice in HIV bio-behavioural surveys in key populations that written consent is not asked for, but an oral consent. Following is added:

After they gave an oral consent to participate, a survey staff member signed an informed consent form on their behalf. The Ethics Committee approved this consent procedure.

Please provide more information on the coupons given out as part of recruitment.

More information is now provided in Methods:

Each coupon had its unique number that enabled to link participants with those who gave them coupons to participate in the study. Coupon numbers enable to monitor recruitment chains and issue secondary incentives, and are also necessary for RDS data analysis. Coupons also contained information about the address of the study site and time-period when the study site is open.

We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly.

There are no legal or ethical restrictions on sharing these data publicly.

We uploaded the anonymized data set necessary to replicate study finding as part of submission.

Reviewer 1

Major:

Could the author explain the reason for choosing the three cities as the research site? How representative are the results of these three cities?

These three cities were selected for IBBS in 2018 because IBBS were done in 2015 in these three cities. By repeating surveys in the same cities over time, changes in HIV indicators over time can be assessed. These three cities were selected in 2015 (and 2018) because they are in the most populous provinces in Sri Lanka named Western Province (Colombo), Central Province (Kandy), and Southern Province (Galle) and because of estimated population size of FSW.

This explanation is added at the end of Introduction.

Minor:

1.There is a lack of background data on sexual risk behaviors and HIV testing among female sex workers in Sri Lanka in the introduction part. Please provide more data if possible.

Thank you, more data are added on sexual risk behaviours and HIV testing in Introduction.

2.Please clarify the reason for choosing “consistent condom use with a non-paying partner for 30 days” as the indicator in sample size estimation.

We chose this indicator because this is an important indicator of sexual behaviours in FSW. We could not base sample size calculation on prevalence of infections because of low prevalence estimates from IBBS in FSW in 2015.

3.Please add more details of the measurement of Sexual risk behaviors since it is one of the major outcomes.

This is added now to Methods

4.Please clarify why only the result of Colombo was weighted in table 1.

All prevalence estimates were weighted. This is corrected now in Table 1.

5.Please provide the statistical testing results (like P-value) in the comparison between two rounds of the survey in different cities in table 2. (2015 versus 2018)

We compared now all indicators collected in the 2015 and 2018 surveys using chi-square test, and denoted with a symbol * in Table 2 where there is significant differences (p<0.05) in values.

6.Please mark the significance of aOR in table 3.

This is now marked with an *

Reviewer 2

1. In the introduction, the authors should introduce why they chose the three places (Colombo, Galle and Kandy) as the study sites?

This is now added to the Introduction.

2. The authors should provide a further implication of this study, not only to monitor and further characteristics HIV-related risk behaviors, uptake of HIV prevention services and HIV prevalence?

We provided several implications for programmatic interventions, in particular need to expand community-based HIV testing, address financial and social vulnerabilities and focus on empowerment-based approaches.

We added now a need for interventions to focus on promoting consistent condom use across all types of partnerships and increase skills in negotiating condom use.

1. Is the FSW collected in 2015 and 2018 the same group? Is there any difference between the FSW in 2015 and 2018? Could the authors add the data of 2015 and compared with that of 2018 in Table 1 for the demographic characteristics?

We added some demographic data on FSW recruited in 2015 to the paragraph in Results under socio-demographic characteristics. We thought that this is better than adding data to Table 1.

2. The unit of age in Table 1 should be added.

This is added to Table 1

3. Can you rearrange the contents of Table 2 logically, which is very difficult to read. Also, can you compare the knowledge about HIV, sexual behaviors and health care utilization between 2015 and 2018?

We re-arranged the contents of Table 2 so that it is more logical. We compared now all indicators collected in the 2015 and 2018 survey using chi-square test, and denoted with a sign of * in the Table 2 where there is significant differences (p<0.05)

4. If the author compares the differences between the three regions, more information may be provided.

We provided more information on socio-economic differences between Colombo, Galle and Kandy in Introduction. This information was collected in DHS in 2016.

Discussion

The author should add more information about the three study sites of social economics, which could give more information to explain the differences of factors associated not being tested for HIV in the past 12 months or not knowing HIV positive status among FSW.

As stated above, we provided more information on socio-economic differences between Colombo, Galle and Kandy in Introduction. This information was collected in DHS in 2016.

Implications of these data is discussed in Discussion.

2. Selection bias may be a limitation in this study.

Agree, this is added to Limitations.

Attachment

Submitted filename: Response to reviewers.docx

Decision Letter 1

Zixin Wang

25 Aug 2020

PONE-D-20-14017R1

HIV prevalence, sexual risk behaviours and HIV testing among female sex workers in three cities in Sri Lanka: Findings from respondent-driven sampling surveys

PLOS ONE

Dear Dr. Bozicevic,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Oct 09 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Zixin Wang, PhD.

Academic Editor

PLOS ONE

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: No

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors have addressed all of the questions from the last review.

But it would be better if the author can provide more information regarding the following suggestion:

1. Sample size calculation:

the author explained in the last response that using ‘condom use with a non-paying partner’ to calculate sample size was due to the importance of condom use, however, there are several behavioral indicators including testing for HIV/knowing one’s status, which is the outcome of the regression. It would be better if the author could calculate sample sizes with other indicators and compare them with the current sample size to demonstrate the power of the current choice. If other calculated sample sizes were larger, limitations should be addressed in discussion.

2. The outcome:

First, the outcome of regression is “not testing or not knowing one’s status”, yet in table 2, there was one variable named “tested or know”. It would be good if the author can clarify if the rates of these two variables are complementary and the sum of them is 1. If so, should the outcome of regression be “not testing and not knowing”? Please ensure the accuracy of the expression.

Second, as was mentioned in the discussion, the rate of “Recent HIV testing” ranged from 17.2% to 39.5%. However, after reading table 2 carefully, the variables that match this expression is “tested for HIV in the past 12 months or knowing HIV positive status”. Though the HIV positive rates were low in this study, it was not appropriate to mix these two indicators in the abstract and discussion. Please revise.

Third, the number of 17.2% in the second suggestion wasn’t displayed in table2. The closest number was 17.1 and 17.5. Please make sure there is no typo.

3. The discussion:

The author provided statistical testing between data in 2015 and 2018. And there were many significant results, which haven’t been referred to or deeply discussed in the discussion part. It would be better if the author could provide more insight into the reason of changes from 2015 to 2018, as well as implication for policy makers.

4. Uses with dots and commas:

In paragraph one of introduction, both line one and line five have displayed a confusing mixture of dots and commas. Please proofread the paper and make sure such uses are consistent within the manuscript.

Reviewer #2: The author has made a good modification according to the comments, but some minor revisions are still should be taken.

Introduction:

In the last paragraph, the author should write the research hypothesis rather than the results of the demographic and health survey.

In Table 2

The first column can be classified by knowledge, behavior and health care utilization.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2020 Oct 1;15(10):e0239951. doi: 10.1371/journal.pone.0239951.r004

Author response to Decision Letter 1


10 Sep 2020

We provided Responses to reviewers as a separate file

Comments of Reviewer 1

Responses of the authors

1. Sample size calculation:

the author explained in the last response that using ‘condom use with a non-paying partner’ to calculate sample size was due to the importance of condom use, however, there are several behavioral indicators including testing for HIV/knowing one’s status, which is the outcome of the regression. It would be better if the author could calculate sample sizes with other indicators and compare them with the current sample size to demonstrate the power of the current choice. If other calculated sample sizes were larger, limitations should be addressed in discussion.

We did the calculation of sample sizes for several other indicators including “tested for HIV in the past 12 months or knowing one’s status” and “comprehensive knowledge about HIV prevention” but that yielded smaller sample sizes compared to ‘condom use with a non-paying partner’.

Used condom at last sex with a client was not used to calculate the sample size as the value of this indicator was already high in the 2015 IBBS, so a large sample size would have been needed to detect a small change in this indicator.

Final samples sizes that we calculated and the number of FSW recruited - 458 FSW in Colombo, 360 in Galle and 362 in Kandy – is comparable to IBBS done in KPs in other settings.

2. The outcome:

First, the outcome of regression is “not testing or not knowing one’s status”, yet in table 2, there was one variable named “tested or know”. It would be good if the author can clarify if the rates of these two variables are complementary and the sum of them is 1. If so, should the outcome of regression be “not testing and not knowing”? Please ensure the accuracy of the expression.

Second, as was mentioned in the discussion, the rate of “Recent HIV testing” ranged from 17.2% to 39.5%. However, after reading table 2 carefully, the variables that match this expression is “tested for HIV in the past 12 months or knowing HIV positive status”. Though the HIV positive rates were low in this study, it was not appropriate to mix these two indicators in the abstract and discussion. Please revise.

Third, the number of 17.2% in the second suggestion wasn’t displayed in table2. The closest number was 17.1 and 17.5. Please make sure there is no typo. The outcome of regression is “not being tested for HIV in the past 12 months or not knowing HIV positive status”. This is in the title of the Table 3.

Now, we added this clarification to the the columns of Table 3.

In Table 2, the outcome is “Tested for HIV in the past 12 months or knowing HIV positive status”.

The sum of these proportions is 1.

This is right, we corrected this so that instead of “recent HIV testing” it stands “tested for HIV in the past 12 months or knowing HIV positive status”.

It should be 17.5% - this is now corrected in Abstract and Discussion

3. The discussion:

The author provided statistical testing between data in 2015 and 2018. And there were many significant results, which haven’t been referred to or deeply discussed in the discussion part. It would be better if the author could provide more insight into the reason of changes from 2015 to 2018, as well as implication for policy makers.

We provided a discussion about significant differences in some results, in particular HIV testing, condom use and comprehensive knowledge about HIV prevention.

The implication of results in terms of development of HIV response in FSW is addressed later on in Discussion.

Uses with dots and commas:

In paragraph one of introduction, both line one and line five have displayed a confusing mixture of dots and commas. Please proofread the paper and make sure such uses are consistent within the manuscript.

This was corrected in the Introduction, and checked in other parts of the manuscript.

Reviewer 2

Introduction:

In the last paragraph, the author should write the research hypothesis rather than the results of the demographic and health survey.

Research hypothesis was added to the Introduction (We hypothesised that there will be a significant increase in condom use with non-paying partners and ever testing for HIV when 2015 data are compared with 2018.)

During the first round of review, the other reviewer suggested to add results on demographics in these three cities.

In Table 2

The first column can be classified by knowledge, behavior and health care utilization.

This is added now to classify indicators

Attachment

Submitted filename: Response to reviewers.docx

Decision Letter 2

Zixin Wang

16 Sep 2020

HIV prevalence, sexual risk behaviours and HIV testing among female sex workers in three cities in Sri Lanka: Findings from respondent-driven sampling surveys

PONE-D-20-14017R2

Dear Dr. Bozicevic,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Zixin Wang, PhD.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Zixin Wang

21 Sep 2020

PONE-D-20-14017R2

HIV prevalence, sexual risk behaviours and HIV testing among female sex workers in three cities in Sri Lanka: Findings from respondent-driven sampling surveys

Dear Dr. Bozicevic:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Professor Zixin Wang

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File

    (SAV)

    S2 File

    (SAV)

    S3 File

    (SAV)

    Attachment

    Submitted filename: Response to reviewers.docx

    Attachment

    Submitted filename: Response to reviewers.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES